DK152791D0 - Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved - Google Patents

Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved

Info

Publication number
DK152791D0
DK152791D0 DK152791A DK152791A DK152791D0 DK 152791 D0 DK152791 D0 DK 152791D0 DK 152791 A DK152791 A DK 152791A DK 152791 A DK152791 A DK 152791A DK 152791 D0 DK152791 D0 DK 152791D0
Authority
DK
Denmark
Prior art keywords
semisynthesis
procedure
human insulin
achromobacter protease
achromobacter
Prior art date
Application number
DK152791A
Other languages
English (en)
Other versions
DK152791A (da
Inventor
Masami Soejima
Takeharu Masaki
Jyoji Nagaoka
Yoshitsugu Sakata
Akinori Shintani
Nobuaki Minamii
Tetsuya Matsuo
Haruhiko Sugiyama
Nobuyuki Tokioka
Hideya Suzuki
Original Assignee
Wako Pure Chem Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6823882A external-priority patent/JPS58187186A/ja
Priority claimed from JP12391782A external-priority patent/JPS5914798A/ja
Priority claimed from JP57162976A external-priority patent/JPS5951789A/ja
Priority claimed from JP57169428A external-priority patent/JPS5959189A/ja
Application filed by Wako Pure Chem Ind Ltd filed Critical Wako Pure Chem Ind Ltd
Publication of DK152791A publication Critical patent/DK152791A/da
Publication of DK152791D0 publication Critical patent/DK152791D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK152791A 1982-04-23 1991-08-29 Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved DK152791D0 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6823882A JPS58187186A (ja) 1982-04-23 1982-04-23 固定化酵素
JP12391782A JPS5914798A (ja) 1982-07-16 1982-07-16 ヒトインシユリンの半合成法
JP57162976A JPS5951789A (ja) 1982-09-18 1982-09-18 安定化酵素
JP57169428A JPS5959189A (ja) 1982-09-28 1982-09-28 新規なアルカリプロテア−ゼ

Publications (2)

Publication Number Publication Date
DK152791A DK152791A (da) 1991-08-29
DK152791D0 true DK152791D0 (da) 1991-08-29

Family

ID=27464963

Family Applications (2)

Application Number Title Priority Date Filing Date
DK182483A DK182483A (da) 1982-04-23 1983-04-25 Fremgangsmaade til semi-syntese af humant insulin og alkalisk protease til anvendelse derved
DK152791A DK152791D0 (da) 1982-04-23 1991-08-29 Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK182483A DK182483A (da) 1982-04-23 1983-04-25 Fremgangsmaade til semi-syntese af humant insulin og alkalisk protease til anvendelse derved

Country Status (3)

Country Link
EP (2) EP0092829B1 (da)
DE (1) DE3381980D1 (da)
DK (2) DK182483A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801022A (en) * 1990-08-03 1998-09-01 Vertex Pharmaceuticals, Incorporated Method of producing a product with crosslinked crystals of thermolysin
ATE323158T1 (de) * 1990-08-03 2006-04-15 Vertex Pharma Verwendung von vernetzten kristallen als neue form von immobilisierung von enzymen
US5618710A (en) * 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
AU2091397A (en) * 1996-03-12 1997-10-01 Novo Nordisk A/S Novel achromobacter lyticus protease variants
US7396903B2 (en) * 2001-11-19 2008-07-08 Novo Nordisk A/S Process for preparing insulin compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (da) * 1968-03-29 1973-01-31
US4251631A (en) * 1978-02-23 1981-02-17 Research Products Rehovot Ltd. Cross-linked enzyme membrane
JPS54119085A (en) * 1978-03-09 1979-09-14 Takeda Chem Ind Ltd Alkaliprotease
NO153061C (no) * 1979-04-13 1986-01-08 Shionogi & Co Fremgangsmaate for fremstilling av et b30-threonininsulin
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
DE3101382A1 (de) * 1981-01-17 1982-09-02 Hoechst Ag, 6000 Frankfurt "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"
WO1982004069A1 (en) * 1981-05-20 1982-11-25 Andresen Finn Hede A process for the preparation of insulin derivatives
EP0085083B1 (en) * 1981-08-10 1985-01-23 Nordisk Insulinlaboratorium Process for the enzymatic preparation of human insulin
US4601979A (en) * 1981-09-15 1986-07-22 Nordisk Insulinlaboratorium Process for preparing human insulin or B-30 esters thereof

Also Published As

Publication number Publication date
DK182483A (da) 1983-10-24
DK152791A (da) 1991-08-29
EP0092829A3 (en) 1985-08-21
EP0092829A2 (en) 1983-11-02
EP0367302A3 (en) 1991-06-19
EP0367302A2 (en) 1990-05-09
DK182483D0 (da) 1983-04-25
EP0092829B1 (en) 1990-11-07
DE3381980D1 (de) 1990-12-13

Similar Documents

Publication Publication Date Title
DK559586A (da) Fremgangsmaade til direkte indfoering af dna i plastider og mitochondrier
DK139589D0 (da) Indretning omfattende midler til beskyttelse og udlevering af fluidumsensitivt laegemiddel
DK318583A (da) N-(bicyklisk heterocyklyl)-4-piperidinaminer og fremgangsmaader til fremstilling deraf
DK269186D0 (da) Dipeptidforbindelser med farmaceutisk virkning og praeparater indeholdende disse
DK162385D0 (da) Implanterbare praeparater af regulatoriske peptider med styret frigoerelse og fremgangsmaade til fremstilling heraf
DK162137C (da) Engangsble og fremgangsmaade til fremstilling deraf
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK491483A (da) Ophthalmisk praeparat og fremgangsmaade til fremstilling heraf
DK251286A (da) Syntetiske vacciner mod mund- og klovsyge og fremgangsmaade til fremstilling af saadanne vacciner
DK450584D0 (da) Ekspressionsvektorer og anvendelse deraf til fremstilling af et protein med aktiviteten af humant antitrypsin-alfa1
DK204884D0 (da) Gaerudtrykkelsesmedium,gaerorganisme transformeret dermed og fremgangsmaade til fremstilling af et for gaer heterologt protein
IT1153181B (it) Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana
DK158682A (da) Fremgangsmaade til fremstilling af azopigmentpraeparater og disses anvendelse
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
DK152791D0 (da) Fremgangsmaade til semisyntese af humant insulin og achromobacter protease i til anvendelse derved
DK590883D0 (da) Saltsyrepraeparater og anvendelse heraf
DK360884D0 (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
DK221689D0 (da) Naturstensplade og fremgangsmaade til fremstilling af naturstensplade
DK422984D0 (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK106089A (da) Fremgangsmaade til fremstilling af alkansulfonylhalogenider og alkansulfonsyrer
DK131189D0 (da) Fremgangsmaade og middel til ophthalmisk anaestesi
DK515987A (da) N-(omega-cyanoalkyl)aminophenol og fremgangsmaade til fremstilling deraf
DK276686A (da) Fremgangsmaade og apparat til behandling af sortlud
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment